Distinct Alterations of Inflammatory Biomarkers in Cluster Headache: A Case Control Study

Area of Science:

• Neurology
• Immunology
• Biochemistry

Background:

• Cluster headache is a severe neurological disorder with poorly understood pathophysiology.
• The role of the immune system, particularly cytokines, in cluster headache is an emerging area of research.
• Understanding immune system alterations may reveal novel therapeutic targets and predictive biomarkers.

Purpose of the Study:

• To investigate immune system involvement in cluster headache by analyzing cytokine profiles.
• To compare cytokine levels in patients with chronic cluster headache, episodic cluster headache (in bout and remission), and healthy controls.
• To explore the potential of specific cytokines to predict disease phenotype, such as chronic versus episodic cluster headache.

Main Methods:

• A prospective case-control study involving 412 participants from the Danish Cluster Headache Biobank.
• Measurement of 45 cytokines in individuals with cluster headache (diagnosed per International Classification of Headache Disorders, 3rd edition) and age/sex-matched controls.
• Statistical analysis, including logistic regression, to identify significant cytokine alterations and associations with disease state.

Main Results:

• Significant alterations in cytokine levels were observed across all three cluster headache states (episodic in bout, episodic in remission, chronic) compared to controls.
• Oncostatin M was significantly elevated in all cluster headache patient groups compared to controls, indicating a potential systemic immune response.
• Interleukin-1β (IL-1β) was significantly associated with chronic cluster headache phenotype in a logistic regression model, suggesting its role in disease chronification.

Conclusions:

• The immune system is demonstrably altered in all clinical states of cluster headache.
• Elevated Oncostatin M presents a promising avenue for future therapeutic interventions in cluster headache.
• Distinct cytokine profiles between episodic and chronic cluster headache highlight the need for further research into immune system roles in predicting disease activity and treatment response.